Cargando…
Systemic Nos2 Depletion and Cox inhibition limits TNBC disease progression and alters lymphoid cell spatial orientation and density
Antitumor immune polarization is a key predictor of clinical outcomes to cancer therapy. An emerging concept influencing clinical outcome involves the spatial location of CD8(+) T cells, within the tumor. Our earlier work demonstrated immunosuppressive effects of NOS2 and COX2 tumor expression. Here...
Autores principales: | Somasundaram, Veena, Ridnour, Lisa A., Cheng, Robert YS., Walke, Abigail J., Kedei, Noemi, Bhattacharyya, Dibyangana D., Wink, Adelaide L., Edmondson, Elijah F., Butcher, Donna, Warner, Andrew C., Dorsey, Tiffany H., Scheiblin, David A., Heinz, William, Bryant, Richard J., Kinders, Robert J., Lipkowitz, Stanley, Wong, Stephen TC., Pore, Milind, Hewitt, Stephen M., McVicar, Daniel W., Anderson, Stephen K., Chang, Jenny, Glynn, Sharon A., Ambs, Stefan, Lockett, Stephen J., Wink, David A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661390/ https://www.ncbi.nlm.nih.gov/pubmed/36375380 http://dx.doi.org/10.1016/j.redox.2022.102529 |
Ejemplares similares
-
Interferon-gamma is quintessential for NOS2 and COX2 expression in ER(-) breast tumors that lead to poor outcome
por: Cheng, Robert Y. S., et al.
Publicado: (2023) -
Coexpression of NOS2 and COX2 accelerates tumor growth and reduces survival in estrogen receptor-negative breast cancer
por: Basudhar, Debashree, et al.
Publicado: (2017) -
Nitric Oxide Modulates Metabolic Processes in the Tumor Immune Microenvironment
por: McGinity, Christopher L., et al.
Publicado: (2021) -
Inducible nitric oxide synthase-derived extracellular nitric oxide flux regulates proinflammatory responses at the single cell level
por: Somasundaram, Veena, et al.
Publicado: (2019) -
An in vitro tumorigenesis model based on live-cell-generated oxygen and nutrient gradients
por: Gilmore, Anne C., et al.
Publicado: (2021)